The emerging treatment of the medication represents a exciting advance in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide078133.onzeblog.com/42202915/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment